This important study reports the development of the first tankyrase degrader and demonstrates its enhanced ability to inhibit β-catenin signaling compared to conventional tankyrase inhibitors. The ...

Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer, today announced preliminary clinical data demonstrating the ...

FDA fast track designation facilitates expedited development of DPTX3186, recognizing its potential to address serious unmet ...

Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells.

FDA grants Fast Track designation to DPTX3186, Dewpoint’s first in class condensate modulator for gastric cancerDesignation provides increased FDA engagement, rolling review eligibility, and potential ...

Scientists may have just cracked the code behind gray hair—without dye, drugs, or genetics. A hidden flaw inside your hair follicles could be to blame, and researchers say it might be fixable.

Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its complex linker, demonstrating a powerful, ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by differences in communication, behavior and ...